Phil B.FontanarosaMD, Deputy EditorIndividualAuthorMargaret A.WinkerMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Fishbein FellowIndividualAuthor
To the Editor: Drs Rochon and Gurwitz1 document specific underuse of proven therapies
and properly encourage application of effective agents for "seniors (65 years
and older)." However, for purposes of pharmacological management, all elderly
patients should not be grouped together because they fall roughly into 2 cohorts,
those younger than 75 years and those of the rapidly increasing population
aged 75 years or older. For the older group, reliable prospective studies
are rare because they are complicated by multiple morbidities, frequent compromise
of 1 or more organ systems, and substantial interindividual variability of
general health. Because of these pathophysiological problems and sparse data,
most decisions for older elderly patients will continue to be individualized
and less accurately defined.
Lesser GT, Libow LS. Prescribing for Elderly Persons. JAMA. 2000;283(3):339–340. doi:10-1001/pubs.JAMA-ISSN-0098-7484-283-3-jac90010
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: